THE POSSIBILITIES OF COMPLEX VISUAL DIAGNOSTICS OF LIVER PATHOLOGY IN PATIENTS WITH DIFFUSE LIVER DISEASES ASSOCIATED WITH COVID-19.

A. Telesh; T. Morozova

doi:10.31618/ESSA.2782-1994.2021.4.75.173

Автор(и)

A. Telesh Department of Radiology of Smolensk State Medical University
T. Morozova Department of Radiology of Smolensk State Medical University

DOI:

https://doi.org/10.31618/ESSA.2782-1994.2021.4.75.173

Ключові слова:

diffuse liver disease, diagnostics, COVID-19, arterial spin labeling, magnetic resonance imaging.

Анотація

The research shows the possibilities of visual diagnostics of liver pathology in patients with various diffuse liver diseases and COVID-19. The analysis is based on the results of examination of patients, who got hospital treatment in Clinical Hospital №1 of Smolensk from September to November 2021. The research shows the efficiency of ultrasound diagnosis as the first step of examination.

Using Magnetic Resonance Imaging (MRI) allowed to study the symptoms of liver pathology more deeply. In order to improve the exact specific diagnosis of liver pathology in patients with diffuse liver diseases and COVID-19, arterial spin labeling technique is recommended to use. The research shows the efficiency of complex using of diagnostic methods in patients with diffuse liver diseases and SARS-CoV-2 infection

Біографії авторів

A. Telesh , Department of Radiology of Smolensk State Medical University

PhD student

T. Morozova , Department of Radiology of Smolensk State Medical University

MD, DSc, Head of the Department

Посилання

Vernon G. Baranova A. Younossi Z.M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults.Aliment Pharmacol Ther. 2011; 34: 274-285

Martin Blachier, Henri Leleu, Markus PeckRadosavljevic, Dominique-Charles Valla and Françoise Roudot-Thoraval The Burden of liver disease in Europe. A review of available epidemiological data. 2013

Ascha M.S. Hanouneh I.A. Lopez R. Tamimi T.A. Feldstein A.F. Zein N.N. The incidence and risk factor of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology. 2010; 51: 1972-1978

Cadranel J. Good clinical practice guidelines for fine needle aspiration biopsy of the liver: past, present and future. Gastroenterol. Clin. Biol. 2002; 26: 823–824. PMID: 12434092

Hope TA, Ohliger MA, Qayyum A: MR imaging of diffuse liver disease: from technique to diagnosis. Radiol Clin North Am. 2014, 52:709–724. 10.1016/j.rcl.2014.02.016

Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY). 2017 Feb;42(2):490-501. doi: 10.1007/s00261-016-0913-6. PMID: 27678393

Ho ML. Arterial spin labeling: Clinical applications. J Neuroradiol. 2018 Sep;45(5):276-289. doi: 10.1016/j.neurad.2018.06.003. Epub 2018 Jul 27. PMID: 30016705

Morozova T.G., Simakina E.N., Gel't T.D. Osnovnye kriterii ASL-perfuzii pecheni pri virusnyh gepatitah. Medicinskaja vizualizacija. 2021;25(1):73-79 [Morozova T.G., Simakina E.N., Gelt T.D. The main criteria for ASL-perfusion of the liver in viral hepatitis. Medical Visualization. 2021;25(1):73-79. (In Russ.)].

https://doi.org/10.24835/1607-0763-932

Trufanov G.E. , Fokin V.A. , Asaturjan E.G. , Efimcev A.Ju., Shmedyk N.Ju., Mashhenko I.A., Chegina D.S. , Aldatov R.H. Metodika arterial'nogo spinovogo markirovanija: klinicheskoe primenenie. REJR 2019; 9(4):129-147. [Trufanov G.E., Fokin V.A., Asaturyan E.G., Efimtsev A.Yu., Shmedyk N.Yu., Mashchenko I.A., Chegina D.S., Aldatov R.Kh. Arterial spin labeling: slinical applications. REJR 2019; 9(4):129-147. (In Russ.)]DOI:10.21569/2222-7415-2019-9-4-129-147

Lee I.C., Huo T.I., Huang Y.H. Gastrointestinal and Liver Manifestations in Patients with COVID-19. J. Chin. Med. Assoc. 2020; 10.1097/JCMA.0000000000000319. https://doi.org/10.1097/JCMA.0000000000000319

Vinokurov A.S., Nikiforova M.V., Oganesjan A.A., Vinokurova O.O., Judin A.L., Jumatova E.A. COVID-19. Porazhenie pecheni – osobennosti vizualizacii i vozmozhnye prichiny. Medicinskaja vizualizacija. 2020; 24 (3): 26–36. [Vinokurov A.S., Nikiforova M.V., Oganesyan A.A., Vinokurova O.O., Yudin A.L., Yumatova E.A. COVID-19. Liver damage – visualization features and possible causes. Medical Visualization. 2020; 24 (3): 26–36. (In Russ.)] https://doi.org/10.24835/1607-0763-2020-3-26-36

Gambino R. Cassader M. Pagano G. Metaanalysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of noninvasive tests for liver disease severity. Annals of Medicine. 2011; 43 (G): 617-649